Lincoln Pharmaceuticals' board is planning to consider and approve draft scheme of amalgamation of its subsidiary -- Lincoln Parenteral (The Transferor Company) with Lincoln Pharmaceuticals (The Transferee Company). The company’s board at their meeting to be held on September 19, 2019, to consider the same.
Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectable, Syrups and Ointments.
